CH

Chris Hirst

Chief Executive Officer

Bespak

Holmes Chapel, England


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Bespak
Industry
pharmaceuticals
Employees
550.0
Seniority
C suite
Annual Revenue
140000000.0

Technologies

SMTP.com Outlook Microsoft Office 365 Zendesk CloudFlare Hosting Hubspot Mobile Friendly DoubleClick Conversion Google Tag Manager Hotjar Google Dynamic Remarketing Linkedin Marketing Solutions Vimeo DoubleClick

Keywords

inhaled nasal drug delivery pressurised metered dose inhalers pmdi valves actuators dose counters formulation product development pilotscale clinical commercialscale manufacturing low gwp propellants drug delivery devices plastic injection moulding pulmonary nasal cdmo innovation sustainability pharmaceutical manufacturing pmdi soft mist inhalers dry powder inhalers nasal delivery devices medical check valves device contract manufacturing hfa propellants low carbon propellants analytical & formulation development commercialization drug product development device design clinical supply scale up technological innovation customised actuators unit dose devices multi-dose systems nasal spray technology biological formulations mrna vaccines patient adherence regulatory approval commercial manufacturing environmental footprint aerosol performance quality assurance gmp compliance high-speed automated assembly liquid formulations formulation compatibility customised drug delivery deep nasal delivery nebulisation devices soft mist nebulisers ergonomic device design real-time dose indication high volume manufacture pharmaceutical device industry new drug applications cdmo services supply chain collaboration integrated drug delivery systems medical device inflation valves environmental services renewables & environment pharmaceuticals medical

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans